These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1137 related items for PubMed ID: 8858937

  • 1. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 2. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T, Lamensdorf I, Finberg JP.
    Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
    [Abstract] [Full Text] [Related]

  • 3. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
    Finberg JP, Wang J, Goldstein DS, Kopin IJ, Bankiewicz KS.
    J Neurochem; 1995 Sep; 65(3):1213-20. PubMed ID: 7643100
    [Abstract] [Full Text] [Related]

  • 4. In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism.
    Brannan T, Prikhojan A, Martínez-Tica J, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1995 Sep; 10(2-3):79-89. PubMed ID: 9620056
    [Abstract] [Full Text] [Related]

  • 5. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.
    Hársing LG, Vizi ES.
    Br J Pharmacol; 1984 Nov; 83(3):741-9. PubMed ID: 6439273
    [Abstract] [Full Text] [Related]

  • 6. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
    Sivam SP.
    Neuropeptides; 1993 Jul; 25(1):35-45. PubMed ID: 7692341
    [Abstract] [Full Text] [Related]

  • 7. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW.
    J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
    [Abstract] [Full Text] [Related]

  • 8. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T, Dong B, Ishii K, Kinemuchi H.
    J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
    [Abstract] [Full Text] [Related]

  • 9. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S, Mukai T, Kurosaki K, Kuriiwa F, Endo T.
    Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
    [Abstract] [Full Text] [Related]

  • 10. Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma.
    Hovevey-Sion D, Kopin IJ, Stull RW, Goldstein DS.
    Neuropharmacology; 1989 Aug; 28(8):791-7. PubMed ID: 2506486
    [Abstract] [Full Text] [Related]

  • 11. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
    Di Monte DA, DeLanney LE, Irwin I, Royland JE, Chan P, Jakowec MW, Langston JW.
    Brain Res; 1996 Oct 28; 738(1):53-9. PubMed ID: 8949927
    [Abstract] [Full Text] [Related]

  • 12. Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolism.
    Azzaro AJ, King J, Kotzuk J, Schoepp DD, Frost J, Schochet S.
    J Neurochem; 1985 Sep 28; 45(3):949-56. PubMed ID: 3928811
    [Abstract] [Full Text] [Related]

  • 13. Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain.
    Lakshmana MK, Rao BS, Dhingra NK, Ravikumar R, Govindaiah, Sudha S, Meti BL, Raju TR.
    Neurochem Res; 1998 Aug 28; 23(8):1031-7. PubMed ID: 9704592
    [Abstract] [Full Text] [Related]

  • 14. Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease.
    Youdim MB, Tipton KF.
    Parkinsonism Relat Disord; 2002 Mar 28; 8(4):247-53. PubMed ID: 12039419
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA, Juorio AV, Berry MD, Zhu MY.
    J Pharmacol Exp Ther; 1991 Sep 28; 258(3):1019-26. PubMed ID: 1679846
    [Abstract] [Full Text] [Related]

  • 16. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
    Aluf Y, Vaya J, Khatib S, Loboda Y, Finberg JP.
    Neuropharmacology; 2013 Feb 28; 65():48-57. PubMed ID: 22982254
    [Abstract] [Full Text] [Related]

  • 17. Modification of dopamine release by selective inhibitors of MAO-B.
    Finberg JP, Lamensdorf I, Armoni T.
    Neurobiology (Bp); 2000 Feb 28; 8(2):137-42. PubMed ID: 11061211
    [Abstract] [Full Text] [Related]

  • 18. Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo.
    Lamensdorf I, Porat S, Simantov R, Finberg JP.
    Br J Pharmacol; 1999 Feb 28; 126(4):997-1002. PubMed ID: 10193780
    [Abstract] [Full Text] [Related]

  • 19. Effect of MAO inhibitors on the uptake and metabolism of dopamine in rat and human brain.
    Tekes K, Tóthfalusi L, Gaál J, Magyar K.
    Pol J Pharmacol Pharm; 1988 Feb 28; 40(6):653-8. PubMed ID: 3152003
    [Abstract] [Full Text] [Related]

  • 20. Microdialysis perfusion of COA-Cl enhances dopamine metabolism in the dorsal striatum of freely moving mice.
    Jamal M, Tsukamoto I, Takei S, Miki T, Kinoshita H, Takehiko M.
    Acta Neurobiol Exp (Wars); 2024 Oct 11; 84(3):256-265. PubMed ID: 39392021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.